首页> 美国政府科技报告 >Specific, Reversible Cytostatic Protection of Normal Cells Against Chemotherapeutics in Breast Cancer Therapy
【24h】

Specific, Reversible Cytostatic Protection of Normal Cells Against Chemotherapeutics in Breast Cancer Therapy

机译:正常细胞对乳腺癌治疗中化疗药物的特异性,可逆性细胞抑制保护

获取原文

摘要

The adverse effects of cancer chemotherapy are widely recognized. Hair loss, gastrointestinal discomfort, lethargy and anorexia are quite common. The cause for these events is the nonspecific nature of current cancer treatment agents. Cytotoxic drugs, while effective at killing proliferating tumor cells, also target normal dividing cells. It is the purpose of this study to develop a proven in vitro strategy to protect normal dividing tissues using a cytostatic agent, UCN-01. There reversible arrest of normally dividing tissues in mice will be examined for improved tolerance of chemotherapeutics. This protective effect will also be evaluated in mice bearing orthotopically implanted breast tumors.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号